Tokyo, Nov. 13 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063602) titled 'A Study to Evaluate the Usability of a Digital App for Treating Depression' on Nov. 12.
Study Type:
Observational
Primary Sponsor:
Institute - Otsuka Pharmaceutical Co., Ltd.
Condition:
Condition - Healthy adults
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To confirm that the Japanese-language user interface of a digital therapeutic app for patients with major depressive disorder can be used safely and appropriately by Japanese users and that use-related problems attributable to the user interface have been adequately reduced.
Basic objectives2 - Others
Eligi...